Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE

Clinical trial NCT05030831 · COMPLETED

Trial details

NCT number: NCT05030831
Sponsor: Inozyme Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ATP-Binding Cassette Subfamily C Member 6 Deficiency Pseudoxanthoma Elasticum Generalized Arterial Calcification of Infancy

Start date: 2022-04-11
Primary completion: 2024-07-09
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.